Pilar Mori Vara

Prof. Dr. Pilar Mori Vara

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Metas de Enfermería
Verified
Journal Article
Closed access
LGLaura Álvarez Gómez
Laura Álvarez Gómez
PVPilar Mori Vara
Pilar Mori Vara
MSMª Carmen Gómez Sánchez
Mª Carmen Gómez Sánchez

30 April 2025 in Nursing Reports
Verified
Journal Article
Open access
PDF file
AHAna Casaux Huertas
Ana Casaux Huertas
PVPilar Mori Vara
Pilar Mori Vara
MCMARIA DEL CARMEN HERNANDEZ CEDIEL
MARIA DEL CARMEN HERNANDEZ CEDIEL
David Hernán-GascueñaDavid Hernán-Gascueña
David Hernán-Gascueña
Rosa M Cárdaba-GarcíaRosa M Cárdaba-García
Rosa M Cárdaba-García
CDCarlos Durántez
Carlos Durántez
Background: Chronic kidney disease (CKD) has a significant impact on patients’ physical, psychological, and social well-being. Emotional disorders are common and contribute to a higher prevalence of symptoms compared to that in the general population. This study aimed to analyze the relationship between the emotional profiles and symptomatology in patients undergoing hemodialysis (HD). Methods: A multicenter, cross-sectional, observational/analytical study was developed in seven centers of the Spanish Renal Foundation in the Community of Madrid (Spain). The study protocol was reviewed and approved by the Clinical Research Ethics Committee of Hospital Clínico San Carlos, Madrid (C.I. 20/685-E). In the study, two validated measurement scales were used: the Mood Rating Scale (EVEA) to assess the “emotional profile” and the Palliative care Outcome Scale, Renal Symptoms (POS-S Renal) to evaluate “symptomatology”. Results: The sample (245 patients) was predominantly male (65.7%; n = 161), with a mean age of 63.52 years (SD = 14.99) and an average HD treatment duration of 81.44 months (SD = 96.62). The analysis of the symptom–emotion relationships revealed that patients with a sadness–depression profile had a higher probability of experiencing weakness or a lack of energy (OR = 1.741; CI 95% 1.01–3.00) and feelings of depression (OR = 3.236; CI 95% 1.98–5.30). Additionally, patients with an anger–hostility profile exhibited a significant association with pain (OR = 3.463; CI 95% 1.34–8.94) and excessive sleepiness (OR = 3.796; CI 95% 1.21–11.95), indicating that this emotional state substantially increases the likelihood of developing these symptoms. Conclusions: The emotional profiles of CKD patients undergoing HD significantly influence their symptomatology. While positive emotions may play a protective role in preventing debilitating symptoms, negative emotions increase the risk of their onset. These findings highlight the importance of addressing emotional well-being as part of comprehensive care for HD patients.

30 March 2026 in Enfermería Nefrológica
Verified
Journal Article
Open access
PDF file
AHAna Casaux Huertas
Ana Casaux Huertas
PVPilar Mori Vara
Pilar Mori Vara
MCMARIA DEL CARMEN HERNANDEZ CEDIEL
MARIA DEL CARMEN HERNANDEZ CEDIEL
DGDavid Hernán Gascueña
David Hernán Gascueña
Introduction: Chronic kidney disease causes physicalalterations that affect quality of life and increase the presence of symptoms. The accumulation of uraemic toxins contributes to a chronic inflammatory state associated with a higher symptomatic prevalence. The aim of the study was to identify the most frequent symptoms in patients on haemodialysis.Material and Method: Multicentre cross-sectional studyin patients with chronic kidney disease on haemodialysis.Symptoms were assessed using the Renal POS-S Scale.Descriptive analyses and logistic regressions were performed to explore the relationship between symptomatology and clinical and sociodemographic variables.Results: Among the 245 patients included, most reported absence of symptoms or non-limiting symptoms. The most frequent were pain, weakness, and sleep disturbances. Women showed a higher probability of pain and constipation. Age was associated with an overall increase in symptoms, whereas a higher Kt showed a protective effect, reducing the probability of poor appetite and limited mobility. Interdialytic weight gain increased the risk of sleep problems, and a higher Charlson Comorbidity Index was associated with reduced mobility and weakness, as well as pain, drowsiness, pruritus, or depression.Conclusions: The most frequent symptoms in patients with advanced chronic kidney disease on haemodialysis were pain, weakness, and sleep problems. Variables such as sex, age, comorbidity, time on dialysis, Kt, and interdialytic weight gain significantly influenced their occurrence, highlighting the importance of a comprehensive approach focused on clinical and sociodemographic factors.